Literature DB >> 27681353

XIAP deficiency and MEFV variants resulting in an autoinflammatory lymphoproliferative syndrome.

Mette Christiansen1, Sandra Ammann2, Carsten Speckmann2, Trine Hyrup Mogensen3.   

Abstract

A 16-year-old boy of Caucasian ethnicity was evaluated for recurrent febrile episodes occurring during most of his life without establishment of any microbial aetiology. During febrile episodes he developed extensive splenomegaly, lymphadenopathy, anaemia, severe abdominal pain and general malaise. Lymph node biopsies demonstrated inflammation and sinus histiocytosis but no malignancy or granuloma. The patient underwent seroconversion for Epstein-Barr virus (EBV) infection during the hospitalisation. Genetic testing identified a hemizygous frameshift mutation in the X linked inhibitor of apoptosis (XIAP)-gene as well as variants in the MEFV gene indicating Familial Mediterranean Fever (FMF). XIAP expression was markedly reduced in the patient, while a functional assay assessing tumour necrosis factor (TNF)α production of monocytes in response to NOD2 stimulation displayed reduced activity. We suggest that the heterozygous MEFV variants and the hemizygous XIAP variant in combination triggered the prolonged and pathological inflammatory response to EBV infection. 2016 BMJ Publishing Group Ltd.

Entities:  

Year:  2016        PMID: 27681353      PMCID: PMC5051366          DOI: 10.1136/bcr-2016-216922

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  23 in total

1.  The prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever.

Authors:  Merav Lidar; Marina Yaqubov; Nurit Zaks; Shomron Ben-Horin; Pnina Langevitz; Avi Livneh
Journal:  J Rheumatol       Date:  2006-06       Impact factor: 4.666

2.  XIAP mediates NOD signaling via interaction with RIP2.

Authors:  Andreas Krieg; Ricardo G Correa; Jason B Garrison; Gaëlle Le Negrate; Kate Welsh; Ziwei Huang; Wolfram T Knoefel; John C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

Review 3.  Inhibitor of apoptosis (IAP) proteins in regulation of inflammation and innate immunity.

Authors:  Rune B Damgaard; Mads Gyrd-Hansen
Journal:  Discov Med       Date:  2011-03       Impact factor: 2.970

4.  Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).

Authors:  Jana Pachlopnik Schmid; Danielle Canioni; Despina Moshous; Fabien Touzot; Nizar Mahlaoui; Fabian Hauck; Hirokazu Kanegane; Eduardo Lopez-Granados; Ester Mejstrikova; Isabelle Pellier; Lionel Galicier; Claire Galambrun; Vincent Barlogis; Pierre Bordigoni; Alain Fourmaintraux; Mohamed Hamidou; Alain Dabadie; Françoise Le Deist; Filomeen Haerynck; Marie Ouachée-Chardin; Pierre Rohrlich; Jean-Louis Stephan; Christelle Lenoir; Stéphanie Rigaud; Nathalie Lambert; Michèle Milili; Claudin Schiff; Helen Chapel; Capucine Picard; Geneviève de Saint Basile; Stéphane Blanche; Alain Fischer; Sylvain Latour
Journal:  Blood       Date:  2010-11-30       Impact factor: 22.113

5.  Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation.

Authors:  Rebecca A Marsh; Gretchen Vaughn; Mi-Ok Kim; Dandan Li; Sonata Jodele; Sarita Joshi; Parinda A Mehta; Stella M Davies; Michael B Jordan; Jack J Bleesing; Alexandra H Filipovich
Journal:  Blood       Date:  2010-09-20       Impact factor: 22.113

Review 6.  Modulation of immune signalling by inhibitors of apoptosis.

Authors:  Shawn T Beug; Herman H Cheung; Eric C LaCasse; Robert G Korneluk
Journal:  Trends Immunol       Date:  2012-07-24       Impact factor: 16.687

7.  Familial Mediterranean fever with a single MEFV mutation: where is the second hit?

Authors:  Matthew G Booty; Jae Jin Chae; Seth L Masters; Elaine F Remmers; Beverly Barham; Julie M Le; Karyl S Barron; Steve M Holland; Daniel L Kastner; Ivona Aksentijevich
Journal:  Arthritis Rheum       Date:  2009-06

8.  X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis.

Authors:  C Speckmann; K Lehmberg; M H Albert; R B Damgaard; M Fritsch; M Gyrd-Hansen; A Rensing-Ehl; T Vraetz; B Grimbacher; U Salzer; I Fuchs; H Ufheil; B H Belohradsky; A Hassan; C M Cale; M Elawad; B Strahm; S Schibli; M Lauten; M Kohl; J J Meerpohl; B Rodeck; R Kolb; W Eberl; J Soerensen; H von Bernuth; M Lorenz; K Schwarz; U Zur Stadt; S Ehl
Journal:  Clin Immunol       Date:  2013-07-31       Impact factor: 3.969

Review 9.  Familial Mediterranean fever--a review.

Authors:  Mordechai Shohat; Gabrielle J Halpern
Journal:  Genet Med       Date:  2011-06       Impact factor: 8.822

10.  Familial Mediterranean fever without MEFV mutations: a case-control study.

Authors:  Ilan Ben-Zvi; Corinne Herskovizh; Olga Kukuy; Yonatan Kassel; Chagai Grossman; Avi Livneh
Journal:  Orphanet J Rare Dis       Date:  2015-03-25       Impact factor: 4.123

View more
  2 in total

Review 1.  Recent advances in understanding inhibitor of apoptosis proteins.

Authors:  Najoua Lalaoui; David Lawrence Vaux
Journal:  F1000Res       Date:  2018-12-03

Review 2.  Evolution of Our Understanding of XIAP Deficiency.

Authors:  Anne C A Mudde; Claire Booth; Rebecca A Marsh
Journal:  Front Pediatr       Date:  2021-06-17       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.